Jefferies Group LLC Chemo Centryx, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $225,335 - $526,495	10,164 New	10,164 $3,000
Q2 2021 Sep 21, 2023	BUY	$9.59 - $50.88 $380,051 - $2.02 Million	39,630 Added 389.91%	49,794 $666,000
Q2 2021 Aug 16, 2021	BUY	$9.59 - $50.88 $477,428 - $2.53 Million	49,784 Added 497840.0%	49,794 $667,000
Q1 2020 May 15, 2020	SELL	$32.73 - $50.78 $642,162 - $996,303	-19,620 Reduced 99.95%	10 $0
Q3 2019 Nov 13, 2019	BUY	$6.47 - $8.96 $127,006 - $175,884	19,630 New	19,630 $133,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.